Individual-level transitions between chronic disease multimorbidity clusters and the risk of five-year mortality in longitudinal cohort of Chinese middle-aged and older adults.
Xiashan Dong, Yiming Ma, Huizi Zhang, Peigang Wang
{"title":"Individual-level transitions between chronic disease multimorbidity clusters and the risk of five-year mortality in longitudinal cohort of Chinese middle-aged and older adults.","authors":"Xiashan Dong, Yiming Ma, Huizi Zhang, Peigang Wang","doi":"10.1007/s40520-025-03078-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We aimed to trace individual's transition between multimorbidity clusters and examine the addictive and compounding effects of transition trajectories, chronic disease accumulation, and five-year all-cause mortality.</p><p><strong>Methods: </strong>Participants from the China Health and Retirement Longitudinal Study (2011-2020) were included (N = 8988). Latent class analyses, Cox proportional hazard models, and restricted cubic splines were used to examine the associations.</p><p><strong>Results: </strong>Five clusters were identified: osteoarticular, cardiometabolic, multisystem, digestive, and respiratory. Participants who had multisystem multimorbidity and further developed respiratory diseases had mortality risk 9 times higher than the healthy participants (HR:9.04; 95% CI 3.44-23.73). For participants experienced prolonged cardiometabolic multimorbidity, the mortality risk increased by 26% with each additional chronic disease and by 38% with each additional body system affected between 2011 and 2015.</p><p><strong>Conclusion: </strong>Subsequent interventions should prioritize those who experienced prolonged multi-system multimorbidity, developed respiratory diseases from existing multi-system conditions, or developed additional chronic diseases from existing cardiometabolic multimorbidity.</p>","PeriodicalId":7720,"journal":{"name":"Aging Clinical and Experimental Research","volume":"37 1","pages":"216"},"PeriodicalIF":3.4000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12241155/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging Clinical and Experimental Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40520-025-03078-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: We aimed to trace individual's transition between multimorbidity clusters and examine the addictive and compounding effects of transition trajectories, chronic disease accumulation, and five-year all-cause mortality.
Methods: Participants from the China Health and Retirement Longitudinal Study (2011-2020) were included (N = 8988). Latent class analyses, Cox proportional hazard models, and restricted cubic splines were used to examine the associations.
Results: Five clusters were identified: osteoarticular, cardiometabolic, multisystem, digestive, and respiratory. Participants who had multisystem multimorbidity and further developed respiratory diseases had mortality risk 9 times higher than the healthy participants (HR:9.04; 95% CI 3.44-23.73). For participants experienced prolonged cardiometabolic multimorbidity, the mortality risk increased by 26% with each additional chronic disease and by 38% with each additional body system affected between 2011 and 2015.
Conclusion: Subsequent interventions should prioritize those who experienced prolonged multi-system multimorbidity, developed respiratory diseases from existing multi-system conditions, or developed additional chronic diseases from existing cardiometabolic multimorbidity.
背景:我们的目的是追踪个体在多发病群之间的转变,并检查转变轨迹、慢性疾病积累和5年全因死亡率的成瘾性和复合效应。方法:纳入来自中国健康与退休纵向研究(2011-2020)的参与者(N = 8988)。使用潜在类别分析、Cox比例风险模型和受限三次样条来检验相关性。结果:鉴定出5类:骨关节、心脏代谢、多系统、消化和呼吸。患有多系统多病并进一步发展为呼吸系统疾病的参与者的死亡风险是健康参与者的9倍(HR:9.04;95% ci 3.44-23.73)。2011年至2015年期间,患有长期心脏代谢多发病的参与者,每增加一种慢性疾病,死亡风险增加26%,每增加一种身体系统受影响,死亡风险增加38%。结论:后续的干预措施应优先考虑那些经历了长期多系统多病,从现有的多系统疾病发展为呼吸系统疾病,或从现有的心脏代谢多病发展为其他慢性疾病的患者。
期刊介绍:
Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.